Protein profiling of ovarian cancers by immunohistochemistry to identify potential target pathways

di Foss, Cassandra D, Dalton, Heather J, Monk, Bradley J, Chase, Dana M, Farley, John H
Pubblicato in Gynecol Oncol Res Pract (2014)

Activity of bevacizumab-containing regimens in recurrent low-grade serous ovarian or peritoneal cancer: A single institution experience

di Dalton, Heather J., Fleming, Nicole D., Sun, Charlotte C., Bhosale, Priya, Schmeler, Kathleen M., Gershenson, David M.
Pubblicato in Gynecol Oncol (2017)

Monocyte Subpopulations in Angiogenesis

di Dalton, Heather J., Armaiz-Pena, Guillermo, Gonzalez-Villasana, Vianey, Lopez-Berestein, Gabriel, Bar-Eli, Menashe, Sood, Anil K.
Pubblicazione 2014

In vitro chemoresponse in metachronous pairs of gyneclologic cancers

di Dalton, Heather J, Fiorica, James, McClure, Candace K, Rocconi, Rodney P, Recio, Fernando O, Levocchio, John L, Burrell, Matthew O, Monk, Bradley J
Pubblicato in Gynecol Oncol Res Pract (2014)

Comprehensive epigenetic analysis of Notch pathway in high-grade serous ovarian cancer

di Ivan, Cristina, Hu, Wei, Bottsford-Miller, Justin, Zand, Behrouz, Dalton, Heather J., Liu, Tao, Huang, Jie, Nick, Alpa M., Lopez-Berestein, Gabriel, Coleman, Robert L., Baggerly, Keith A., Sood, Anil K.
Pubblicazione 2012

PTEN expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer

di Thanapprapasr, Duangmani, Previs, Rebecca A., Hu, Wei, Ivan, Cristina, Armaiz-Pena, Guillermo N., Dorniak, Piotr L., Hansen, Jean M., Rupaimoole, Rajesha, Huang, Jie, Dalton, Heather J., Ali-Fehmi, Rouba, Coleman, Robert L., Sood, Anil K.
Pubblicato in Mol Cancer Ther (2015)

Dual metronomic chemotherapy with nab-paclitaxel and topotecan has potent anti-angiogenic activity in ovarian cancer

di Previs, Rebecca A., Armaiz-Pena, Guillermo N., Lin, Yvonne G., Davis, Ashley N., Pradeep, Sunila, Dalton, Heather J., Hansen, Jean M., Merritt, William M., Nick, Alpa M., Langley, Robert R., Coleman, Robert L., Sood, Anil K.
Pubblicato in Mol Cancer Ther (2015)

Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer

di Reusser, Nicole M, Dalton, Heather J, Pradeep, Sunila, Gonzalez-Villasana, Vianey, Jennings, Nicholas B, Vasquez, Hernan G, Wen, Yunfei, Rupaimoole, Rajesh, Nagaraja, Archana S, Gharpure, Kshipra, Miyake, Takahito, Huang, Jie, Hu, Wei, Lopez-Berestein, Gabriel, Sood, Anil K
Pubblicazione 2014

Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer

di Wen, Yunfei, Graybill, Whitney S., Previs, Rebecca A., Hu, Wei, Ivan, Cristina, Mangala, Lingegowda S., Zand, Behrouz, Nick, Alpa M., Jennings, Nicholas B., Dalton, Heather J., Sehgal, Vasudha, Ram, Prahlad, Lee, Ju-Seog, Vivas-Mejia, Pablo E., Coleman, Robert L., Sood, Anil K.
Pubblicato in Clin Cancer Res (2014)

Role of Focal Adhesion Kinase in Regulating YB–1–Mediated Paclitaxel Resistance in Ovarian Cancer

di Kang, Yu, Hu, Wei, Ivan, Cristina, Dalton, Heather J., Miyake, Takahito, Pecot, Chad V., Zand, Behrouz, Liu, Tao, Huang, Jie, Jennings, Nicholas B., Rupaimoole, Rajesha, Taylor, Morgan, Pradeep, Sunila, Wu, Sherry Y., Lu, Chunhua, Wen, Yunfei, Huang, Jianfei, Liu, Jinsong, Sood, Anil K.
Pubblicazione 2013

Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth

di Huang, Jie, Hu, Wei, Hu, Limin, Previs, Rebecca A., Dalton, Heather J., Yang, Xiao-Yun, Sun, Yunjie, McGuire, Michael, Rupaimoole, Rajesha, Nagaraja, Archana S, Kang, Yu, Liu, Tao, Nick, Alpa M., Jennings, Nicholas B., Coleman, Robert L., Jaffe, Robert B., Sood, Anil K.
Pubblicato in Mol Cancer Ther (2016)

MOLECULAR BIOMARKERS OF RESIDUAL DISEASE AFTER SURGICAL DEBULKING OF HIGH-GRADE SEROUS OVARIAN CANCER

di Tucker, Susan L., Gharpure, Kshipra, Herbrich, Shelley M., Unruh, Anna K., Nick, Alpa M., Crane, Erin K., Coleman, Robert L., Guenthoer, Jamie, Dalton, Heather J., Wu, Sherry Y., Rupaimoole, Rajesha, Lopez-Berestein, Gabriel, Ozpolat, Bulent, Ivan, Cristina, Hu, Wei, Baggerly, Keith A., Sood, Anil K.
Pubblicazione 2014

Differential platelet levels affect response to taxane-based therapy in ovarian cancer

di Bottsford-Miller, Justin, Choi, Hyun-Jin, Dalton, Heather J., Stone, Rebecca L., Cho, Min Soon, Haemmerle, Monika, Nick, Alpa M., Pradeep, Sunila, Zand, Behrouz, Previs, Rebecca A., Pecot, Chad V., Crane, Erin King, Hu, Wei, Lutgendorf, Susan K., Afshar-Kharghan, Vahid, Sood, Anil K.
Pubblicato in Clin Cancer Res (2014)

Autocrine Effects of Tumor-Derived Complement

di Cho, Min Soon, Vasquez, Hernan G., Rupaimoole, Rajesha, Pradeep, Sunila, Wu, Sherry, Zand, Behrouz, Han, Hee-Dong, Rodriguez-Aguayo, Cristian, Bottsford-Miller, Justin, Huang, Jie, Miyake, Takahito, Choi, Hyun-Jin, Dalton, Heather J., Ivan, Cristina, Baggerly, Keith, Lopez-Berestein, Gabriel, Sood, Anil K., Afshar-Kharghan, Vahid
Pubblicazione 2014

Focal adhesion kinase: An alternative focus for anti-angiogenesis therapy in ovarian cancer

di Stone, Rebecca L, Baggerly, Keith A, Armaiz-Pena, Guillermo N, Kang, Yu, Sanguino, Angela M, Thanapprapasr, Duangmani, Dalton, Heather J, Bottsford-Miller, Justin, Zand, Behrouz, Akbani, Rehan, Diao, Lixia, Nick, Alpa M, DeGeest, Koen, Lopez-Berestein, Gabriel, Coleman, Robert L, Lutgendorf, Susan, Sood, Anil K
Pubblicazione 2014

Rac1/Pak1/p38/MMP-2 axis regulates angiogenesis in ovarian cancer

di Gonzalez-Villasana, Vianey, Fuentes-Mattei, Enrique, Ivan, Cristina, Dalton, Heather J., Rodriguez-Aguayo, Cristian, Fernandez-de Thomas, Ricardo J., Aslan, Burcu, Monroig, Paloma del C., Velazquez-Torres, Guermarie, Previs, Rebecca A., Pradeep, Sunila, Kahraman, Nermin, Wang, Huamin, Kanlikilicer, Pinar, Ozpolat, Bulent, Calin, George, Sood, Anil K., Lopez-Berestein, Gabriel
Pubblicato in Clin Cancer Res (2015)

Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer

di Huang, Yan, Hu, Wei, Huang, Jie, Shen, Fangrong, Sun, Yunjie, Ivan, Cristina, Pradeep, Sunila, Dood, Robert, Haemmerle, Monika, Jiang, Dahai, Mangala, Lingegowda S., Noh, Kyunghee, Hansen, Jean M, Dalton, Heather J., Previs, Rebecca A., Nagaraja, Archana S., McGuire, Michael, Jennings, Nicholas B., Broaddus, Russell, Coleman, Robert L., Sood, Anil K.
Pubblicato in Mol Cancer Ther (2017)

Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth

di Armaiz-Pena, Guillermo N., Gonzalez-Villasana, Vianey, Nagaraja, Archana S., Rodriguez-Aguayo, Cristian, Sadaoui, Nouara C., Stone, Rebecca L., Matsuo, Koji, Dalton, Heather J., Previs, Rebecca A., Jennings, Nicholas B., Dorniak, Piotr, Hansen, Jean M., Arevalo, Jesusa M.G., Cole, Steve W., Lutgendorf, Susan K., Sood, Anil K., Lopez-Berestein, Gabriel
Pubblicato in Oncotarget (2014)

A Core Human Primary Tumor Angiogenesis Signature Identifies the Endothelial Orphan Receptor ELTD1 as a Key Regulator of Angiogenesis

di Masiero, Massimo, Simões, Filipa Costa, Han, Hee Dong, Snell, Cameron, Peterkin, Tessa, Bridges, Esther, Mangala, Lingegowda S., Wu, Sherry Yen-Yao, Pradeep, Sunila, Li, Demin, Han, Cheng, Dalton, Heather, Lopez-Berestein, Gabriel, Tuynman, Jurriaan B., Mortensen, Neil, Li, Ji-Liang, Patient, Roger, Sood, Anil K., Banham, Alison H., Harris, Adrian L., Buffa, Francesca M.
Pubblicazione 2013

Crosstalk between EphA2 and BRaf/CRaf is a Key Determinant of Response to Dasatinib

di Huang, Jie, Hu, Wei, Bottsford-Miller, Justin, Liu, Tao, Han, Hee Dong, Zand, Behrouz, Pradeep, Sunila, Roh, Ju-Won, Thanapprapasr, Duangmani, Dalton, Heather J., Pecot, Chad V., Rupaimoole, Rajesh, Lu, Chunhua, Fellman, Bryan, Urbauer, Diana, Kang, Yu, Jennings, Nicholas B., Huang, Li, Deavers, Michael T., Broaddus, Russell, Coleman, Robert L., Sood, Anil K.
Pubblicazione 2014